[Effects of clofibride in the rabbit or in normal man, at the beginning or after 15 days of treatment. Effects on plasma lipids in the hours following its administration during fasting, without heparin or during heparin-clearing factor induction].
D000818:Animals; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000031:analogs & derivatives* / Q000494:pharmacology; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008071:Lipoprotein Lipase / Q000378:metabolism*; D008297:Male; D011817:Rabbits; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D005230:Fatty Acids, Nonesterified; D008055:Lipids; D014280:Triglycerides; C007089:clofibride; D006493:Heparin; D002784:Cholesterol; D008071:Lipoprotein Lipase; D002994:Clofibrate
Effets du clofibride chez le lapin ou l'homme normal, au début ou après 15 jours de traitement. Actions sur les lipides plasmatiques dans les heures qui suivent son administration à jeun, en l'absence ou au cours de la réaction de clarification par l'héparine.